Skip to main content
CriticalFDAfda-F-1483-2024UNDECLARED ALLERGEN

Deluxe Roasted Salted Mixed Nuts ITEM NUMBER 99651 UPC: 6-51433-99651-6 SELL BY: 10/09/2024

⚠ Critical Alert — Stop Using Immediately

This product has been flagged with severe risks (undeclared allergen). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.

Category
Units Affected
360
Recall Date
June 20, 2024
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1483-2024.

Undeclared allergen; peanuts

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1483-2024.

Recall ongoing. Follow firm instructions.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Dsd Merchandisers, Inc. or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1483-2024.

DSD Merchandisers, Inc.

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Dsd Merchandisers, Inc. Recall FAQ

Dsd Merchandisers, Inc. is the subject of a food safety report: Deluxe Roasted Salted Mixed Nuts ITEM NUMBER 99651 UPC: 6-51433-99651-6 SELL BY: 10/09/2024. The notice was published on June 20, 2024 by the U.S. Food and Drug Administration (FDA). Approximately 360 units are potentially affected.